Total investments 8
Average round size 
$16M
The average size of a deal this fund participated in
Portfolio companies 7
Rounds per year 0.50
Lead investments 2
Follow on index
0.12How often the fund supports its portfolio startups at next rounds
Exits 1
Key employees Soon
Shanghai, China Related Funds
Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Viva Biotech:
Typical Co-investors
Viva Biotech is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Viva Biotech:
There are no funds here. If we find new data, we will add it here.
Look at other 50 related and similar funds Collapse list ↓
| Fund Name | Location |
| 21st Century Internet Venture Partners | California, San Francisco, United States |
| Aetna Ventures | Connecticut, Hartford, United States |
| Almoayed Ventures | Bahrain, Capital Governorate, Manama |
| AtlasInvest | Belgium, Brussels, Brussels Hoofdstedelijk Gewest |
| Beijing Chunfeng Wanhua Touzi Guanli Youxian Gongsi | Beijing, China, Haidian |
| Counterpart Advisors | California, Manhattan Beach, United States |
| CREATE Partners | Cambridge, Cambridgeshire, United Kingdom |
| Dimension | Japan, Tokyo |
| Frontier Ventures | California, Cupertino, United States |
| Fujisawa Investments for Entrepreneurship | Evanston, Illinois, United States |
| Gallatin Point Capital | Connecticut, Greenwich, United States |
| Kajima Corp | Chiba Prefecture, Japan, Tateyama |
| lastminute.com group | Chiasso, Switzerland, Ticino |
| Media Camp | Burbank, California, United States |
| Middleton Enterprises | Newcastle upon Tyne, North East, United Kingdom |
| Monestier Capital | - |
| Nike Accelerator | Beaverton, Oregon, United States |
| PS Alliance | Kyonggi-do, Seongnam, South Korea |
| Quilvest Private Equity | France, Ile-de-France, Paris |
| Uberis Capital | Cambodia, Phnom Penh |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Eubulus | $10M | 14 Oct 2021 | Jiaxing, Zhejiang, China | ||
Totient | $10M | 10 Sep 2020 | Cambridge, Massachusetts, United States | ||
Triumvira Immunologics | $55M | 27 Aug 2020 | Austin, Texas, United States | ||
Regenacy Pharmaceuticals | $30M | 25 Mar 2020 | Massachusetts, United States | ||
DTx Pharma | $10M | 06 Jan 2020 | San Diego, California, United States |
By posting comments on our website you confirm and acknowledge that:
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
To post a comment or write a complain, please sign in with LinkedIn
Review
- No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Do you represent Viva Biotech?
Get access to manage this page
Found incorrect info? Let us know!
Total investments 8
Average round size 16M
Rounds per year 0.50
Peak activity year 2020
Lead investments 2
Follow on index 0.12
Exits 1
Group Appearance index 1.00
Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Eubulus | $10M | 14 Oct 2021 | Jiaxing, Zhejiang, China | ||
Totient | $10M | 10 Sep 2020 | Cambridge, Massachusetts, United States | ||
Triumvira Immunologics | $55M | 27 Aug 2020 | Austin, Texas, United States | ||
Regenacy Pharmaceuticals | $30M | 25 Mar 2020 | Massachusetts, United States | ||
DTx Pharma | $10M | 06 Jan 2020 | San Diego, California, United States |
